GLP-1 therapy works with your body to control cravings and improve metabolism
Obesity isn’t just a cosmetic issue — it’s one of the biggest health challenges of our time. It raises the risk of heart disease, diabetes, hormonal imbalance, and even certain cancers.
In India, more than 135 million people are overweight or obese, while globally, over 650 million adults face the same struggle. For many in cities like Mumbai, fast-paced lifestyles, stress, and irregular eating habits make it even harder to stay healthy.
At NuHealth Mumbai, we believe managing weight means restoring metabolic balance — not chasing short-term fixes. That’s why we offer advanced, evidence-based solutions like GLP-1 / GIP dual-agonist therapy, a modern medical approach inspired by the same science behind Mounjaro.
This breakthrough treatment helps tackle obesity, insulin resistance, and metabolic disorders at their root — helping you feel healthier, more energetic, and in control again.
GLP-1 / GIP dual-agonist therapy (also known globally as Mounjaro or tirzepatide) was first developed to treat type 2 diabetes. It mimics two natural hormones — GLP-1 and GIP — that help control appetite, insulin release, and blood sugar.
Unlike earlier single-hormone medications like Ozempic, this dual-action therapy works on multiple pathways for more effective and sustainable results.
At NuHealth Mumbai, we believe managing weight means restoring metabolic balance — not chasing short-term fixes. That’s why we offer advanced, evidence-based solutions like GLP-1 / GIP dual-agonist therapy, a modern medical approach inspired by the same science behind Mounjaro.
At NuHealth, this therapy is part of a personalised care plan — paired with nutrition, exercise, and lifestyle guidance for sustainable success.
Struggling to manage your weight despite diet and exercise? Consult a certified specialist to explore if Mounjaro Injection is the right choice for your health goals.
At NuHealth Mumbai, our GLP-1 / GIP dual-agonist therapy goes far beyond shedding kilos — it helps restore metabolic balance and improve overall health. This advanced, hormone-based treatment supports a wide range of conditions linked to weight gain, insulin resistance, and hormonal imbalance.
- Type 2 Diabetes
Initially developed to help manage blood sugar, this therapy effectively lowers HbA1c, improves insulin response, and supports steady glucose levels under medical supervision.
- Metabolic Syndrome
It helps regulate cholesterol, blood pressure, and waist circumference, reducing overall cardiovascular risk while boosting energy and wellbeing.
- Metabolic Syndrome
It helps regulate cholesterol, blood pressure, and waist circumference, reducing overall cardiovascular risk while boosting energy and wellbeing.
- Insulin Resistance & PCOS
By improving insulin sensitivity, it can support women with PCOS, helping balance hormones and manage weight more effectively.
- Fatty Liver (NAFLD)
Gradual, healthy weight loss through this therapy can reduce liver fat and support better liver function.
At NuHealth, every program is customized — blending medical expertise with nutrition, exercise, and lifestyle coaching so results are safe, sustainable, and truly life-changing.
- We monitor blood glucose / HbA1c, weight, and any side-effects (nausea, GI upset, injection-site reactions).
- Labs such as kidney and liver function or thyroid checks may be done at baseline and during follow-up where indicated.
- If you are on insulin or sulfonylureas, we’ll adjust other medications to reduce the risk of hypoglycaemia.
At NuHealth,we don't just prescribe GLP-1 therapies like Mounjaro (Tirzepatide) ,every treatment plan is developed after thorough assessments, metabolic screenings, and detailed consultations. With doctor-led monitoring, nutrition guidance, and regular follow-ups, you’re never navigating your journey alone.. Our state-of-the-art facility ensures a hygienic and discreet environment, supported by a skilled team trained in endocrinological care and lifestyle interventions
There’s no “best” way to manage Type 2 diabetes or obesity. Every person is unique and so is each treatment plan. But GLP-1 agonists may help.
Struggling to manage your weight despite diet and exercise? Consult a certified specialist to explore if Mounjaro Injection is the right choice for your health goals.
When should I call my healthcare provider?
You should have regular appointments with your healthcare provider when taking a GLP-1 agonist to assess how well it’s working.
Otherwise, talk to your provider in the following situations:
- If you develop bothersome side effects.
- If you don’t think it’s working to manage your condition.
- If you’re thinking of stopping the medication.
- If you become pregnant or are thinking of becoming pregnant.
How soon will I see results?
Most individuals begin noticing weight loss within the first 4–6 weeks. Results vary, with significant improvements often visible by the 3-month mark, especially when combined with lifestyle changes.
Will I regain weight after stopping Mounjaro?
Weight regain is possible if lifestyle habits revert. That’s why it’s essential to pair medication with sustainable changes in diet, exercise, and behavior for long-term success.
Is Mounjaro better than Ozempic?
Both drugs work on similar mechanisms, but Mounjaro targets two hormones—GLP-1 and GIP—whereas Ozempic only targets GLP-1. This dual-action approach often leads to more substantial results in weight loss and blood sugar control.
GLP-1 agonists and hypoglycemia?
There’s a low risk of mild low blood sugar (hypoglycemia) episodes if you take a GLP-1 agonist. It can become a serious risk if you take GLP-1s with other medications that lower blood sugar, like sulfonylureas or insulin.
Hypoglycemia is blood sugar that’s lower than 70 mg/dL. Without proper treatment, severe hypoglycemia can be life-threatening. Hypoglycemia symptoms include:
- Shaking or trembling.
- Sweating and chills.
- Dizziness or lightheadedness.
- Weakness.
- Faster heart rate.
- Intense hunger (hyperphagia).
- Difficulty thinking and concentrating.
- Pale skin (pallor).
- Nausea.
To treat hypoglycemia, you need to consume sugar or carbohydrates, like half a banana or half a cup of apple juice.
Can I take GLP-1 agonists during pregnancy?
GLP-1 agonists aren’t safe to take during pregnancy. Animal studies show that these medications cause developmental abnormalities in the fetus.
If you’re able to become pregnant, you should use effective and reliable birth control while taking a GLP-1 agonist. If you become pregnant while taking the medication, see your healthcare provider immediately.
How often do you take GLP-1 agonists?
Your healthcare provider will tell you when and how often to take your medication (usually injections). Be sure to follow their instructions. Visit NuHealth - a GLP-1 Mounjaro clinic in Mumbai to start your journey.
But, in general, the frequencies of the injections are:
- Dulaglutide: Once a week.
- Exenatide: Twice a day.
- Exenatide extended-release: Once a week.
- Liraglutide: Once a day.
- Lixisenatide: Once a day.
- Semaglutide: Once a week.
- Tirzepatide: Once a week.
Semaglutide tablets are a daily medication.
Can I take a GLP-1 agonist if I have Type 1 diabetes?
Researchers are currently studying the safety and effectiveness of GLP-1 agonists for people with Type 1 diabetes (T1D). So far, some studies show that these medications can help lower A1C and help with weight loss in people with T1D.
The FDA hasn’t approved GLP-1 agonists for the treatment of T1D. But some healthcare providers prescribe it off-label. Talk to our GLP-1 expert to see if this is an option for you.
